Philip Lee
Chief Executive Officer chez GeneFab LLC
Fortune : 353 032 $ au 31/03/2024
Profil
Philip Lee was the founder of Senti Sub I, Inc. (founded in 2016), Cellasic Corp.
(founded in 2004), and Senti Biosciences, Inc. (founded in 2016) where he held the titles of Chief Operating Officer, Chief Executive Officer, and Chief Technology Officer respectively.
Currently, he is the Chief Executive Officer at GeneFab LLC since 2023.
Previously, he worked as Head-Cell Culture Systems at EMD Millipore Corp.
and Merck KGaA from 2012 to 2016.
Dr. Lee received his undergraduate degree from Massachusetts Institute of Technology and doctorate degrees from the University of California, Berkeley and the University of California, San Francisco.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
SENTI BIOSCIENCES, INC.
2,05% | 01/02/2023 | 936 424 ( 2,05% ) | 353 032 $ | 31/03/2024 |
Postes actifs de Philip Lee
Sociétés | Poste | Début |
---|---|---|
GeneFab LLC
GeneFab LLC BiotechnologyHealth Technology GeneFab LLC develops and commercializes genetic medicines. The American company was founded in 2023 and the CEO is Philip Lee. | Chief Executive Officer | 01/08/2023 |
Anciens postes connus de Philip Lee
Sociétés | Poste | Fin |
---|---|---|
SENTI BIOSCIENCES, INC. | Founder | 07/08/2023 |
MERCK KGAA | Chief Tech/Sci/R&D Officer | 01/11/2014 |
EMD Millipore Corp.
EMD Millipore Corp. Miscellaneous Commercial ServicesCommercial Services EMD Millipore Corp. engages in the provision of laboratory materials, technologies, and services to the life science industry. The company was founded by Jack Bush in 1954 and is headquartered in Burlington, MA. | Chief Tech/Sci/R&D Officer | 01/01/2014 |
Cellasic Corp.
Cellasic Corp. Packaged SoftwareTechnology Services Cellasic Corp. develops a microfluidic software platform for live cell analysis experiments. The American company was founded by Philip Lee. | Chief Executive Officer | 01/04/2012 |
Senti Sub I, Inc.
Senti Sub I, Inc. BiotechnologyHealth Technology Senti Biosciences, Inc. develops novel therapeutics. It specializes in thetic biology, gene therapy and cell therapy. The company was founded by Timothy K. Lu, Wilson Wong, James J. Collins and Philip Lee in 2016 and is headquartered in South San Francisco, CA. | Founder | - |
Formation de Philip Lee
Massachusetts Institute of Technology | Undergraduate Degree |
University of California, Berkeley | Doctorate Degree |
The University of California, San Francisco | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 2 |
---|---|
MERCK KGAA | Health Technology |
SENTI BIOSCIENCES, INC. | Health Technology |
Entreprise privées | 4 |
---|---|
EMD Millipore Corp.
EMD Millipore Corp. Miscellaneous Commercial ServicesCommercial Services EMD Millipore Corp. engages in the provision of laboratory materials, technologies, and services to the life science industry. The company was founded by Jack Bush in 1954 and is headquartered in Burlington, MA. | Commercial Services |
Senti Sub I, Inc.
Senti Sub I, Inc. BiotechnologyHealth Technology Senti Biosciences, Inc. develops novel therapeutics. It specializes in thetic biology, gene therapy and cell therapy. The company was founded by Timothy K. Lu, Wilson Wong, James J. Collins and Philip Lee in 2016 and is headquartered in South San Francisco, CA. | Health Technology |
Cellasic Corp.
Cellasic Corp. Packaged SoftwareTechnology Services Cellasic Corp. develops a microfluidic software platform for live cell analysis experiments. The American company was founded by Philip Lee. | Technology Services |
GeneFab LLC
GeneFab LLC BiotechnologyHealth Technology GeneFab LLC develops and commercializes genetic medicines. The American company was founded in 2023 and the CEO is Philip Lee. | Health Technology |